Laddar...
LDL Cholesterol, Statins And PCSK 9 Inhibitors
Reduction of low density lipoprotein cholesterol (LDLc) is of vital importance for the prevention of atherosclerotic cardiovascular disease (ASCVD). Statin is the most effective therapy today to lower LDLc by inhibiting HMG-CoA-reductase. However despite intensive statin therapy, there remains a res...
Sparad:
| I publikationen: | Indian Heart J |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Elsevier
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4593843/ https://ncbi.nlm.nih.gov/pubmed/26432726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2015.05.020 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|